FDA Warns Against Use of Contaminated Ultrasound Gel

April 19th, 2012 by admin

The US Food and Drug Administration (FDA) is warning clinicians not to use Other‐Sonic Generic Ultrasound Transmission Gel because of bacterial contamination.
News Alerts

Posted in News Alert, Radiology | Comments Off

First Day of Oral Arguments on ACA: Is the Penalty a Tax?

March 27th, 2012 by admin

The high court must decide whether a ruling on the ACA’s individual mandate must wait until the IRS begins to assess the penalty — or is it a tax? — for noncompliance in 2015.
Medscape Medical News

Posted in Family Medicine/Primary Care, News Alert | Comments Off

EMA Recommends New Warnings on Bone Drug

March 17th, 2012 by admin

The CHMP has confirmed a positive benefit-risk balance for strontium ranelate, but recommends new contraindications and revised warnings.
News Alerts

Posted in Diabetes & Endocrinology, News Alert | Comments Off

EMA Recommends New Warnings on Osteoporosis Drug

March 17th, 2012 by admin

The CHMP has confirmed a positive benefit-risk balance for strontium ranelate, but recommends new contraindications and revised warnings.
News Alerts

Posted in Diabetes & Endocrinology, News Alert | Comments Off

New Silicone Breast Implant Approved by FDA

March 10th, 2012 by admin

The agency cautions, however, that women receiving any silicone breast implant require lifelong monitoring.
FDA Approvals

Posted in News Alert, Plastic Surgery & Aesthetic Medicine | Comments Off

Glenmark Generics Recalls 7 Lots of Oral Contraceptives

February 27th, 2012 by admin

A packaging error has led to both active and inactive norgestimate contraceptive tablets being out of sequence.
News Alerts

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

Proton Pump Inhibitors Linked to C difficile Diarrhea

February 8th, 2012 by admin

The FDA is warning that PPIs may be associated with a higher risk for Clostridium difficile-associated diarrhea, a persistent illness that comes with abdominal pain and fever.
News Alerts

Posted in Gastroenterology, News Alert | Comments Off

Pfizer Recalls 28 Lots of Birth Control Pills

February 1st, 2012 by admin

Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 tablets and 14 lots of the generic version because of the possibility of inexact tablet count or out-of-sequence packaging.
News Alerts

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

Plan B: Sebelius Overrules FDA, Nixes Sale Without ID

December 8th, 2011 by admin

The emergency contraceptive pill stays prescription only for those under 17 years old.
News Alerts

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Provides Update on Drospirenone VTE Risk

October 28th, 2011 by admin

Further analysis of an FDA-funded study provides more evidence that drospirenone-containing oral contraceptives increase risk for venous thromboembolism, the agency says.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

Do Not Give Flu Vaccine by Jet Injection, FDA Says

October 25th, 2011 by admin

Although several jet-injection devices are approved for delivering vaccines and other medications, no influenza vaccine has been cleared for this method of administration.
Medscape Medical News

Posted in Infectious Diseases, News Alert | Comments Off

Protelos and Osseor Under Review by EMA

October 22nd, 2011 by admin

The European Medicines Agency is now reviewing all relevant data on cardiovascular and cutaneous safety concerns for Protelos and Osseor.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Still ‘Concerned’ About Drospirenone VTE Risk

September 27th, 2011 by admin

The US Food and Drug Administration remains concerned about drospirenone-containing oral contraceptives and increased risk for venous thromboembolism.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

Qualitest Oral Contraceptives Recalled

September 17th, 2011 by admin

A packaging error has prompted generic drugmaker Qualitest Pharmaceuticals to recall multiple lots of oral contraceptives.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Strengthens Kidney Risk Warning for Reclast

September 2nd, 2011 by admin

In light of more fatal cases of acute renal failure, the agency is revising the label of zoledronic acid when used for osteoporosis.
Medscape Medical News

Posted in Nephrology, News Alert | Comments Off

FDA Warns Against Fluconazole (Diflucan) in Early Pregnancy

August 3rd, 2011 by admin

The agency says long-term use of fluconazole (Diflucan) in high doses in the first trimester may be associated with birth defects.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Warns Against Counterfeit Morning-After Pill

July 30th, 2011 by admin

An unapproved morning-after pill called Evital has not been shown to be safe or effective in preventing pregnancy, the FDA warns.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Studying Link Between Bisphosphonates, Esophageal Cancer

July 22nd, 2011 by admin

The agency continues to review studies that reach different conclusions on the possible association between esophageal cancer and the widely prescribed drugs for osteoporosis.
Medscape Medical News

Posted in Diabetes & Endocrinology, News Alert | Comments Off

Single Lot of Calcium Gluconate Injection Recalled

July 20th, 2011 by admin

American Regent is voluntarily recalling its calcium gluconate injection, USP, 10% 100 mL pharmacy bulk package, lot number 1006, because some vials may contain silicone particles.
Medscape Medical News

Posted in Diabetes & Endocrinology, News Alert | Comments Off

FDA: Continuing Safety Concerns With Transvaginal Mesh

July 14th, 2011 by admin

The FDA has issued a white paper and a second warning about transvaginal placement of surgical mesh to repair pelvic organ prolapse, saying other options may expose women to less risk.
Medscape Medical News

Posted in General Surgery, News Alert | Comments Off

FDA Warns of Cognitive Delay in Offspring With Valproate

July 1st, 2011 by admin

The FDA is adding cognitive delay to warnings about neural tube defects in children of mothers taking valproate vs other antiepileptic drugs.
Medscape Medical News

Posted in Neurology & Neurosurgery, News Alert | Comments Off

FDA Warns of Cognitive Delay in Offspring With Valproate

July 1st, 2011 by admin

The FDA is adding cognitive delay to warnings about neural tube defects in children of mothers taking valproate vs other antiepileptic drugs.
Medscape Medical News

Posted in Neurology & Neurosurgery, News Alert | Comments Off

Long-Term Complications Likely With Silicone Breast Implants

June 23rd, 2011 by admin

An FDA study of silicone gel-filled breast implants found that the devices are safe and effective, but that women with implants are likely to experience complications.
Medscape Medical News

Posted in News Alert, Plastic Surgery & Aesthetic Medicine | Comments Off

Drug Product Recall Due to Possible Penicillin Contamination

June 4th, 2011 by admin

Concerns over potential cross-contamination of nonpenicillin drug products with penicillin have resulted in a nationwide recall of multiple repackaged products.
Medscape Medical News

Posted in News Alert, Public Health & Prevention | Comments Off

Thermography Not an Alternative to Mammography, FDA Warns

June 3rd, 2011 by admin

The FDA has warned that thermography (the use of infrared cameras to measure heat and blood flow near the body’s surface) is not a substitute for mammography.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Reviews Drospirenone for VTE Risk

June 1st, 2011 by admin

The US Food and Drug Administration has announced that they will further review drospirenone-containing oral contraceptives and venous thromboembolism risk.
Medscape Medical News

Posted in News Alert, Ob/Gyn & Women's Health | Comments Off

FDA Recalls Axxent FlexiShield Mini Silicone Pads

April 15th, 2011 by admin

iCAD Axxent FlexiShield Mini silicone pads with tungsten are subject to a US Food and Drug Administration class I recall.
Medscape Medical News

Posted in News Alert, Radiology | Comments Off

FDA Drops Liver Enzyme Testing Requirement for Ambrisentan

March 5th, 2011 by admin

An FDA review indicates that the risk for liver injury is low, eliminating the need for liver enzyme tests every month. However, women of childbearing age who take the drug still need monthly pregnancy tests.
Medscape Medical News

Posted in News Alert, Pulmonary Medicine | Comments Off

Topiramate Linked to Birth Defects

March 5th, 2011 by admin

New human data show that the prevalence of cleft lips and palates in infants born to women taking topiramate was roughly 3 times higher than that for women taking other antiepileptic drugs.
Medscape Medical News

Posted in Neurology & Neurosurgery, News Alert | Comments Off

Risks With Antipsychotics in Pregnancy Stressed in New Label

February 23rd, 2011 by admin

Taking these medications during the third trimester of pregnancy puts neonates at risk for abnormal muscle movements and withdrawal symptoms.
Medscape Medical News

Posted in News Alert, Psychiatry | Comments Off

« Previous Entries